The Lancet honors my innovative publishing work

A few weeks ago, Brian Owens, writer for the leading medical journal, the Lancet interviewed me on my latest open science project, Dapoxetine for premature ejaculation. He wanted to know why and how I self-publish my work. Today, The Lancet reports: academia gets social. The future of science is emerging. Peer-to-peer science platforms facilitating open peer review processes, providing quick template tools so scientists can self-publish their work, giving everyone open access to knowledge. This is a hopeful direction towards innovative, efficient and meaningful science.

Excerpt: …”Some researchers are already taking that next step. Earlier this year Frederik Feys, a clinical sexologist doing a PhD on the placebo effect in sexual health at the Free University of Brussels, submitted an article examining the use of the drug dapoxetine to treat premature ejaculation to the open-access journal PLOS One. Weeks later, the journal came back saying it could not find enough reviewers. “I just thought, ‘what am I doing’, the specific aim of this work was to try and get results out quickly”, says Feys. So he posted the manuscript on ResearchGate, and invited reviews. One reviewer replied quickly, before the staff at ResearchGate noticed his experiment and helped find more. Soon he had three reviewers, which he says, helped to make the manuscript much better. On Oct 7, Feys became the first scientist to publish a paper solely on ResearchGate. The entire process took around two and a half months. All of the reviewers comments and each draft of the manuscript are available for anyone to download and comment on. So far, the final paper has been downloaded more than 160 times. Feys says using ResearchGate as a publishing platform had several advantages, including being completely free, and taking far less time than a traditional publication. He experienced no problems with having the peer review be done openly.”

read the full article from The Lancet

Geef een reactie